Strategic CFO with consistent success in building, transforming and leading high growth multinational and startup biotechnology and pharmaceutical companies. Currently specializing on working with discovery stage, VC-backed biotechnology companies, advising on company strategy, financial controls, fundraising, intellectual property, contractual matters and all G&A functions. I work with partners to efficiently build and run venture-backed company operations from first dollar through IPO.Fundraising, financial strategy, analysis, process and control background with diverse blend of experience across finance disciplines at biotech companies at all stages of development, from 1 to 3,500 employees. Accomplished in leading finance functions during periods of complexity and growth, while building lasting financial, accounting and cost controls. Focused on driving strategic investments in science while containing costs for investors.Strategic planning; debt and equity capital raises; contract negotiations and cost containment; M&A; SEC and U.S. GAAP; IPO and S-1 filings; due diligence; academic research and license agreements; commercial launch preparation; international expansion; FP&A; budgeting and forecasting; system implementations; process efficiency; shared services; procurement; management and Board reporting; Audit Committee; finance transformation; SOX 404; consolidations; internal controls; cost controls; restructuring.